Optimizing CBT Implementation Among Community Providers Through Internet-based Consultation and Networking (i-CAN)

Although anxiety is one of the most common and debilitating mental health conditions affecting children and adolescents, the vast majority of sufferers do not receive effective treatment. Cognitive-behavioral therapy (CBT) is an evidence-based, frontline treatment for pediatric anxiety, yet many community-based practitioners do not implement CBT with high fidelity, which can detrimentally affect its clinical impact. The goal of this study is to develop and test an online platform to support community providers' effective use of CBT for pediatric anxiety.

Study Overview

• Status: Completed
• Conditions: Anxiety; CBT
• Intervention / Treatment: Behavioral: i-CAN

Detailed Description

Stemming from implementation science and, specifically, the Theory of Planned Behavior, investigators are working alongside community stakeholders to develop a novel, online consultation platform. This platform, termed Internet-based Consultation or Networking (or i-CAN) will utilize a professional navigator (i.e., a provider with CBT expertise), online support and resources, and parallel peer consultation to create a user-friendly and supportive community for providers to get support as they implement CBT. Once finalized, the platform will be tested in the context of a preliminary randomized controlled trial (RCT) with approximately 100 mental healthcare providers who work with anxious children and adolescents. Providers who enroll will be randomly assigned to either the experimental condition (i-CAN) or the control condition (wait-list for i-CAN). The primary outcome of interest is change in intentions to use CBT.

• Study Type: Interventional
• Enrollment (Actual): 100
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Alabama
    • Tuscaloosa, Alabama, United States, 35487
      • Center for Youth Development and Intervention

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• provide direct mental healthcare to anxious youth
• practice in general community within state of Alabama
• agree to try i-CAN

Exclusion Criteria:

• None

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: i-CAN; 18 weeks of access to the online consulting platform	Behavioral: i-CAN; online support and consultation to providers
No Intervention: waitlist control; No offered support or consultation

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Reasoned Action Questionnaire	Questionnaire that assesses instrumental beliefs, perceived norms, and self-efficacy (all related to use of cognitive-behavioral therapy). On the Reasoned Action Questionnaire, higher scores indicate greater intention to use the therapeutic approach. Scores can range from 14 to 90.	18 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Evidence-based practice attitude scale	Questionnaire that assesses views toward cognitive-behavioral therapy. Higher scores indicate more positive views. Scores can range from 0 to 60.	18 weeks

Collaborators and Investigators

• Sponsor: University of Alabama, Tuscaloosa
• Investigators: Principal Investigator: Susan W White, PhD, UA

Study record dates

Study Major Dates

• Study Start (Actual): April 1, 2023
• Primary Completion (Actual): December 1, 2024
• Study Completion (Actual): February 1, 2025

Study Registration Dates

• First Submitted: October 11, 2022
• First Submitted That Met QC Criteria: October 11, 2022
• First Posted (Actual): October 14, 2022

Study Record Updates

• Last Update Posted (Actual): April 3, 2025
• Last Update Submitted That Met QC Criteria: April 1, 2025
• Last Verified: April 1, 2025

More Information

Terms related to this study

• Other Study ID Numbers: A22-0473

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: Data will be shared to NDA, and data requests can be issued directly to NDA.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No